Results 111 to 120 of about 7,593 (192)

Pharmacokinetic Optimization of Radiocopper-Based Theranostic Pretargeting. [PDF]

Mol Pharm
Cornejo MA, Samuels ZV, Dehlavi G, Carter L, Kao WM, Strugala E, Zeglis BM.   +6 more
europepmc   +1 more source

Overcoming Limits of Immunoconjugates [PDF]

Nature Biotechnology, 1991
openaire   +1 more source

In Vitro and In Vivo Comparison of Random versus Site-Specific Conjugation of Bifunctional Chelating Agents to the CD33-Binding Antibody for Use in Alpha- and Beta-Radioimmunotherapy. [PDF]

ACS Omega
Allen KJH, Frank C, Jiao R, Malo ME, Bello M, De Nardo L, Meléndez-Alafort L, Dadachova E.   +7 more
europepmc   +1 more source

Conjugation of anti-HIV gp41 monoclonal antibody to a drug capable of targeting resting lymphocytes produces an effective cytotoxic anti-HIV immunoconjugate. [PDF]

J Virol
Pincus SH, Cole FM, Ober K, Tokmina-Lukaszewska M, Marcotte T, Kovacs EW, Zhu T, Khasanov A, Copié V, Peters T.   +9 more
europepmc   +1 more source

Beyond the hype: Antibody-Drug Conjugates are advancing faster than our clinical strategy. [PDF]

PLoS Med
Notini G, Bianchini G, Pérez-García JM, Cortés J.   +3 more
europepmc   +1 more source

Triple Negative Breast Cancer With Choroidal Metastasis Responsive to Sacituzumab Govitecan and Radiation Therapy. [PDF]

Cancer Rep (Hoboken)
Nafissi N, Mahadevan A, Chiao E, Rijal N, Parajuli R.   +4 more
europepmc   +1 more source

Emerging Advances in Nanomedicine for Targeted Cancer Photoimmunotherapy and Photo-Immunometabolic Therapy. [PDF]

Wiley Interdiscip Rev Nanomed Nanobiotechnol
Chota A, Sarbadhikary P, Abrahamse H, George BP.   +3 more
europepmc   +1 more source

Double metastatic cancer with lung and urothelial carcinoma responding to enfortumab vedotin: a case report and review of the literature. [PDF]

J Med Case Rep
Ravoire M, Vazquez L.
europepmc   +1 more source

PD-1/PD-L1 Cancer Immunotherapeutics Reshape Tumor Microenvironment - Clinical Evidence and Molecular Mechanisms for AI-based Precision Medicine. [PDF]

Clin Rev Allergy Immunol
Lin YY, Ding JL, Shen HT, Lin YM, Adhidjaja EC, Chang SC.   +5 more
europepmc   +1 more source

Response to trastuzumab-deruxtecan in metastatic triple-negative breast cancer with both HER2 mutation and low expression. [PDF]

Einstein (Sao Paulo)
Amarger CD, Rabello MIS, Skaf SC, Moura F, Cassoli JPB, Taranto P, Serrano Usón Junior PL, Kaliks R, Beal JR.   +8 more
europepmc   +1 more source